211 related articles for article (PubMed ID: 29709490)
1. Mental health multimorbidity and poor quality of life in patients with schizophrenia.
Bhalla IP; Stefanovics EA; Rosenheck RA
Schizophr Res; 2018 Nov; 201():39-45. PubMed ID: 29709490
[TBL] [Abstract][Full Text] [Related]
2. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
3. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
[TBL] [Abstract][Full Text] [Related]
4. Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use.
Adan A; Marquez-Arrico JE; Gilchrist G
Health Qual Life Outcomes; 2017 Oct; 15(1):209. PubMed ID: 29061151
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.
Sim K; Chua TH; Chan YH; Mahendran R; Chong SA
J Psychiatr Res; 2006 Oct; 40(7):656-63. PubMed ID: 16904688
[TBL] [Abstract][Full Text] [Related]
6. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
Compton MT; Weiss PS; West JC; Kaslow NJ
Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
[TBL] [Abstract][Full Text] [Related]
7. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
[TBL] [Abstract][Full Text] [Related]
8. Interventions to improve lifestyle and quality-of-life in patients with concurrent mental illness and substance use.
Juel A; Kristiansen CB; Madsen NJ; Munk-Jørgensen P; Hjorth P
Nord J Psychiatry; 2017 Apr; 71(3):197-204. PubMed ID: 27834103
[TBL] [Abstract][Full Text] [Related]
9. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
Green AI
J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
[TBL] [Abstract][Full Text] [Related]
10. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].
Ameller A; Gorwood P
Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239
[TBL] [Abstract][Full Text] [Related]
11. A Change in Perspective: From Dual Diagnosis to Multimorbidity.
Bhalla IP; Rosenheck RA
Psychiatr Serv; 2018 Jan; 69(1):112-116. PubMed ID: 29032702
[TBL] [Abstract][Full Text] [Related]
12. A comparison of schizophrenic patients with or without coexisting substance use disorder.
Farris C; Brems C; Johnson ME; Wells R; Burns R; Kletti N
Psychiatr Q; 2003; 74(3):205-22. PubMed ID: 12918597
[TBL] [Abstract][Full Text] [Related]
13. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
Volavka J
J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
15. Circadian functioning and quality of life in substance use disorder patients with and without comorbid schizophrenia.
Hashemzadeh I; Navarro JF; Adan A
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110623. PubMed ID: 36029929
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional study.
Mortimer AM; Al-Agib AO
Int J Soc Psychiatry; 2007 Mar; 53(2):99-107. PubMed ID: 17472084
[TBL] [Abstract][Full Text] [Related]
17. Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review.
Prat G; Marquez-Arrico JE; Río-Martínez L; Navarro JF; Adan A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110310. PubMed ID: 33775743
[TBL] [Abstract][Full Text] [Related]
18. Substance abuse and cognitive functioning in schizophrenia.
Addington J; Addington D
J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
[TBL] [Abstract][Full Text] [Related]
19. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the "Psychiatric and Addictive Dual Disorder in Italy (PADDI)" Study.
Carrà G; Crocamo C; Borrelli P; Popa I; Ornaghi A; Montomoli C; Clerici M
Compr Psychiatry; 2015 Apr; 58():152-9. PubMed ID: 25591906
[TBL] [Abstract][Full Text] [Related]
20. Medication noncompliance and substance abuse among patients with schizophrenia.
Owen RR; Fischer EP; Booth BM; Cuffel BJ
Psychiatr Serv; 1996 Aug; 47(8):853-8. PubMed ID: 8837158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
